Novo Nordisk A/S (NYSE:NVO)

52.47
Delayed Data
As of Oct 15
 +0.44 / +0.85%
Today’s Change
41.59
Today|||52-Week Range
53.55
+13.89%
Year-to-Date
How Big Can This $8 Billion-Plus Diabetes Drug Class Get?
Sep 26 / MotleyFool.com - Paid Partner Content
Lilly Gets CHMP Nod to Add Heart Indication to Trulicity Label
Sep 23 / Zacks.com - Paid Partner Content
Novo Nordisk's Semaglutide in Tablet Form Gets FDA Approval
Sep 23 / Zacks.com - Paid Partner Content